TLG Capital is a private investment firm which invests in small and medium-sized enterprises (SMEs) across sub-Saharan Africa. TLG believes that social and commercial returns can and should go hand in hand. By investing in the rise of the African consumer, TLG provides international investors (both individual and institutional) with access to the African growth story. 

TLG deploys capital innovatively across the capital structure to optimise returns while minimising risk. Key partners include JCDecaux, CIPLA, Medical Credit Fund and Swedfund. TLG’s Credit Opportunities Fund focuses on US$ denominated structured credit investments that generate private equity returns while mitigating risk through collateral and credit enhancements. 

TLG is committed to tackling persistent challenges and better directing resources towards improving the lives of some of the world’s most vulnerable people. TLG’s investments have had a significant social, environmental and development impact across sub-Saharan Africa and TLG aims specifically to contribute to Sustainable Development Goals 1,3,5,8, and 9:

1. No Poverty
3. Good Health
5. Gender Equality
8. Economic Growth
9. Innovation

Learn more at: https://www.tlgcapital.com/

Cipla Quality Chemical industries

Union Bank of Nigeria

Atlas Mara Ltd.

TLG Capital

The TLG Capital - Future Africa Venture Debt Conference is finally here! 

Today's agenda features - 
1. An introduction from Iyinoluwa Aboyeji and Zain Latif ; 
2. A Venture Debt "101" from Amanda Kabagambe Aum Thacker Luke Mostert Isaac Marshall 
3. Africa's Macro & Credit Outlook from Samuel Sule, CFA
4. Developing ESG & Impact to Achieve Scale from Jane Niedra and Markus Forster
 
We are thrilled to welcome over 500 start-ups; Venture Capitalists; Development Finance Institutions; and thought leaders from across Africa!
 
#TLGCapital #FutureAfrica #venturedebt #startups #venturecapital

On World Malaria Day TLG Capital is proud to re-affirm its commitment to helping combat malaria and achieving US Sustainable Development Goal number 3, which aims to ensure health and wellbeing for all ages. Africa accounts for up to 95% of malaria cases and 96% of fatalities, and TLG’s portfolio continues to distribute anti-malarial medication that will ultimately help eradicate the disease.
 
In East Africa, Cipla Quality Chemicals is one of the foremost contributors to The New Uganda Malaria Elimination Strategy Plan 2021-2025. This strategy aims to reduce malaria infections by 50% , morbidity by 50% and mortality by 75% by 2025. 
 
In Benin, Togo and Guinea, TLG Pharma has distributed over 8 million anti-malarial tablets. TLG’s Investment Professional, Aum Thacker, was recently in West Africa with the team to help cement its growth plans for further development in 2023 and 2024.
 
As an impact investor, TLG is committed to supporting innovative solutions that help reduce the burden of Malaria on its communities! #worldmalariaday #CQCIL #TLGPharma #UNSDGs #Africa

On World Health Day, TLG Capital (TLG) is proud of the impact that our portfolio companies are making in Africa: 

TLG Pharma: Distributed over 284 million EU-compliant medications since 2020 across some of Africa’s poorest countries.

Cipla Quality Chemicals: Manufacturing medication for over 1,000,000 Ugandans currently receiving HIV treatment.

Express Pharmacy: Combatted the rise of counterfeit and expired drugs in Nigeria by providing low and middle communities with verified medication.

However, there remains much to be done to mobilize capital into healthcare from the private sector! As highlighted by the International Finance Corporation, healthcare in Sub-Saharan Africa remains the worst in the world, with few countries able to spend the $40 a year per person that the World Health Organization considers the minimum for basic healthcare. 
 
Health Care In Africa: IFC Report Sees Demand for Investment
 
TLG is committed to helping achieve these goals and continues to develop opportunities in the healthcare sector that help to achieve universal healthcare for everyone, including access to essential medicines and vaccines. #healthcare #africa

“Women are the backbone of any society. They are the first educators, they are the first caregivers, they are the first peace builders.” - Ellen Johnson Sirleaf, former President of Liberia and Nobel Peace Prize laureate

As we celebrate the incredible achievements and contributions of women around the world, it’s also important to reflect on the challenges that women face and the important work to be done.
 
In Africa, where TLG focuses its attention, women-led businesses contribute $105 billion to the continent’s GDP and women drive 70% of African consumer spending, yet there are many barriers to women finding equal participation in economic life.
 
For example:
 
🌱 African women make up 70% of the agricultural workforce but own just 1% of the land
 
🏦 Only 37% of African women have bank accounts
 
🏥 Women are 1.7 times more likely to be infected with HIV than men
 
As an investor in better healthcare, financial inclusion, and consumer empowerment, TLG believes that using a gender lens in investing is essential to improve the opportunities and quality of life for women who work in and are served by these sectors.
 
What are the most important challenges you see to realizing gender equality in Africa? 

How can entrepreneurs and investors take on these challenges?

TLG Capital is an investment holding company that specializes in private equity and venture capital across Africa. The firm focuses on high-growth sectors, aiming to generate strong returns while fostering sustainable development. It partners with promising businesses and provides them with capital, strategic guidance, and operational support to scale their operations.

COM:TLGCAPITAL

TLG Capital

Filings Not Available